Charles Macaluso

CIK 1199536 · last filed 2021-02-08

Charles Macaluso is a corporate insider who has filed 51 SEC Form 4 insider transactions across 5 companies since 2007. Current disclosed insider exposure totals $5.7M across reported positions. 4 SEC filings were submitted jointly with PILGRIMS PRIDE CORP.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Disclosed Exposure

$5.73M

Companies

Total Filings

Lifetime Open-Market Net

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

DAR price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Exposure by company

latest

OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Filer Profile

Related Filers

PILGRIMS PRIDE CORP — 4 joint filings, latest 2020-05-28

Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.

Symbol	Role	Shares	Price	Disclosed Exposure	Lifetime OM Net	Filings	Latest Filed
LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted	Director	5,501	$8.76	$48.2K	$0	3	2020-10-19
PPC	Director	7,746	$28.03	$217.1K	$0	3	2020-05-28
DAR	Director	98,115	$56.16	$5.51M	$0	19	2020-05-06
Williams Industrial Services Group Inc. (GLPW) Delisted	Director	40,474	—	—	$0	5	2015-01-26
GLOBAL CROSSING LTD (GLBC) Delisted	Director	34,219	—	—	$0	14	2011-07-06

Recent Filings

51 filings

Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.

Filed	Symbol	Action	Net Shares	Net $	Link
2021-02-08	—	Grant (A)	+27,398	$0
2020-10-19	LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted	Mixed	+5,501	$57.0K	EDGAR
2020-06-02	LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted	Grant (A)	—	$0	EDGAR
2020-05-28	PPC	Grant (A)	+2,726	$0	EDGAR
2020-05-06	DAR	Grant (A)	+5,363	$0	EDGAR
2020-03-17	—	Grant (A)	+73,171	$0
2020-03-09	—	Exer (M)	+26,589	$34.6K
2020-03-03	DAR	Mixed	+2,754	-$5	EDGAR
2019-10-17	LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted	Grant (A)	—	$0	EDGAR
2019-08-05	PPC	Grant (A)	+2,234	$0	EDGAR

Showing 1–10 of 51

Page 1 of 6 Next

Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.